+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Active Pharmaceutical Ingredients (API) Market Size, Share & Trends Analysis Report By Type Of Synthesis, By Type Of Manufacturer (Captive), By Type (Generic), By Application, By Type Of Drug, By Country, And Segment Forecast, 2023 - 2030

  • PDF Icon

    Report

  • 130 Pages
  • May 2023
  • Region: Europe
  • Grand View Research
  • ID: 5830991
Description Jump to:
The Europe active pharmaceutical ingredients (API) market size is expected to reach USD 66.7 billion by 2030, expandingat a CAGR of 5.75% from 2023 to 2030. The development of the biopharmaceutical industry in the region, the rising elderly population, and improvements in the ease of production of complex active pharmaceutical ingredients (API) are some of the market's key drivers. In addition, the growing prevalence of chronic diseases such as cancer and cardiovascular diseases is further driving the demand for complex drugs and their APIs.

The government is making efforts toward shifting manufacturing of API in European countries to reduce reliance on other nations. For instance, as per Germany Trade and Commerce, Jens Spahn, the Federal Minister for Health of Germany, announced in March 2020, that he intends to start discussions with EU partners on the potential of bringing the manufacturing of active pharmaceutical ingredients (API) back to Germany. As a result, concerns have been raised about the reliability and security of imported APIs and the possibility of supply chain disruptions. As a consequence, domestic production is gaining traction, and regulatory scrutiny for imported products has increased.

The COVID-19 pandemic had a positive impact on the global API market. The pharmaceutical industry was an epicenter for treating symptoms related to COVID-19, including cough, high fever, and cold. With the heightened popularity of the pharmaceutical business during the SARS-COV-2 pandemic, the active pharmaceutical ingredient market also witnessed growth during the period. Following the World Health Organization's declaration of the COVID-19 outbreak as a pandemic, a diverse group of prominent biopharmaceutical and pharmaceutical companies and new startups initiated the manufacturing of active pharmaceutical ingredients. For instance, in February 2023, Advent International introduced a new brand identity for its active pharmaceutical ingredients and CDMO (contract development and manufacturing company), allowing it to focus more on the division.

Furthermore, the market for active pharmaceutical ingredients operates with high complexity. Companies are focusing more on investment to expand their API manufacturing units in order to meet market demand. For instance, Veranova in February 2023, invested USD 8.10 million in API manufacturing expansion in the UK. Growth in the targeted therapy sector has created lucrative opportunities for flexible, small-quantity manufacturers. This is a nontraditional opportunity, as CDMOs are usually considered for outsourcing large batches of API production. With the entry of targeted and precision medicine, the number of patients is expected to decline, which, in turn, is likely to boost demand for flexible small-batch manufacturers to manufacture precision medicines.

Europe Active Pharmaceutical Ingredients (API) Market Report Highlights

  • Synthetic segment dominated the market in 2022 and is attributable to its easy availability compared to natural molecules
  • The captive API segment dominated the market in 2022, owing to high investment by market players to develop high-end manufacturing facilities and the rising trend of reducing third-party dependence in the industry
  • Generic API holds the largest revenue share owing to its cost effectiveness over the branded counterpart
  • The oncology segment is expected to expand with the fastest CAGR due to the high prevalence of the condition around Europe
  • The prescription segment dominates the market since these approaches offer more trust among healthcare providers and patients
  • Germany held the largest market share in 2022, which can be attributed to the presence of multiple prominent manufacturers in the nation along with trade and regulatory support from the government

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Regional scope
1.1.2 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information procurement
1.3.1 Purchased database:
1.3.2 internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.7 Research Assumptions
1.8 Key KoL Responses
1.9 Market share calculations
1.10 List of Secondary Sources
1.11 List of Abbreviations
1.12 Objectives
1.12.1 Objective 1
1.12.2 Objective 2
1.12.3 Objective 3
1.12.4 Objective 4
Chapter 2 Europe Active Pharmaceutical Ingredients Market: Executive Summary
2.1 Segment Outlook
2.2 Competitive Outlook
2.3 Market Outlook
Chapter 3 Europe Active Pharmaceutical Ingredients Market Variables, Trends, and Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.2 Penetration and Growth Prospect Mapping
3.3 User Perspective Analysis
3.4 Market Dynamics
3.4.1 Market Driver Analysis
3.4.1.1 Growing geriatric population
3.4.1.2 Rising prevalence of target diseases such as hospital-acquired infections, genetic, cardiovascular, and neurological diseases
3.4.1.3 Increasing preference for targeted therapy approach in cancer treatment
3.4.1.4 Increasing preference for outsourcing APIs
3.4.2 Market Restraint Analysis
3.4.2.1 High capital investments and production cost
3.4.2.2 Stringent Safety and handling regulations regarding APIs
3.5 Market Analysis Tools
3.5.1 Industry Analysis: Porter’s
3.5.2 PESTLE Analysis
3.5.3 Regulatory Scenario
Chapter 4 Europe Active Pharmaceutical Ingredients Market: Competitive Analysis
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.1.1 Ansoff matrix
4.1.2 Heat map analysis
4.2 Company Categorization
4.2.1 Innovators
4.2.2 Market Leaders
4.3 Vendor Landscape
4.3.1 List of key distributors and channel partners
4.3.2 Key customers
4.3.3 Key company market share analysis, 2022
4.4 Public Companies
4.4.1 Company market position analysis
4.4.2 Company market position analysis
4.4.3 Competitive Dashboard Analysis
4.4.3.1 Market Differentiators
4.5 Private Companies
4.5.1 List of key emerging companies
4.6 Major Deals and Strategic Alliances Analysis
4.6.1 Joint Ventures
4.6.2 Acquisitions
4.6.3 Licensing and Partnerships
4.6.4 Technological Collaborations
Chapter 5 Europe Active Pharmaceutical Ingredients Molecules Outlook
5.1 European Sales of API Molecules, USD Million, 2018 - 2022
5.2 Companies with the leading market position for API molecules
5.2.1 Amoxicillin
5.2.2 Azithromycin
5.2.3 Bleomycin
5.2.4 Caspofungin
5.2.5 Clarithromycin
5.2.6 Clavulanic acid
5.2.7 Clindamycin
5.2.8 Compactin (Mevastatin)
5.2.9 Cyclosporin
5.2.10 Dactinomycin
5.2.11 Daptomycin
5.2.12 Demeclocycline
5.2.13 Doxycycline
5.2.14 Erythromycin
5.2.15 Ivermectin (Avermectin)
5.2.16 Lovastatin
5.2.17 Micafungin
5.2.18 Minocycline
5.2.19 Mitomycin
5.2.20 Mycophenolic acid
5.2.21 Pneumocandin B0
5.2.22 Polymyxin
5.2.23 Pravastatin
5.2.24 Rapamycin (Sirolimus)
5.2.25 Simvastatin
5.2.26 Steroids
5.2.27 Tacrolimus
5.2.28 Tetracycline
5.2.29 Tigecycline
5.2.30 Tobramycin
5.2.31 Vancomycin
Chapter 6 Europe Active Pharmaceutical Ingredients Market: Segment Analysis, by Type of Synthesis, 2018 - 2030 (USD Billion)
6.1 Definition and Scope
6.2 Type of Synthesis Market Share Analysis, 2022 & 2030
6.3 Segment Dashboard
6.4 Europe API Market, by Type of Synthesis, 2018 to 2030
6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
6.5.1 Biotech API
6.5.1.1 Biotech API market, 2018 - 2030 (USD Billion)
6.5.1.2 Biotech API market, By type, 2018 - 2030 (USD Billion)
6.5.1.3 Generic API
6.5.1.3.1 Generic API market, 2018 - 2030 (USD Billion)
6.5.1.4 Innovative API
6.5.1.4.1 Innovative APIs market, 2018 - 2030 (USD Billion)
6.5.1.5 Biotech APIs market, By product (Revenue, USD Billion, 2018 - 2030)
6.5.1.6 Monoclonal Antibodies
6.5.1.6.1 Monoclonal antibodies market, 2018 - 2030 (USD Billion)
6.5.1.7 Hormones
6.5.1.7.1 Hormones market, 2018 - 2030 (USD Billion)
6.5.1.8 Cytokines
6.5.1.8.1 Cytokines market, 2018 - 2030 (USD Billion)
6.5.1.9 Recombinant Proteins
6.5.1.9.1 Recombinant proteins market, 2018 - 2030 (USD Billion)
6.5.1.10 Therapeutic Enzymes
6.5.1.10.1 Therapeutic enzymes market, 2018 - 2030 (USD Billion)
6.5.1.11 Vaccines
6.5.1.11.1 Vaccines market, 2018 - 2030 (USD Billion)
6.5.1.12 Blood Factors
6.5.1.12.1 Blood factors market, 2018 - 2030 (USD Billion)
6.5.2 Synthetic API
6.5.2.1 Synthetic API market, 2018 - 2030 (USD Billion)
6.5.2.2 Synthetic API market, By type (Revenue, USD Billion, 2018 - 2030)
6.5.2.3 Generic API
6.5.2.3.1 Generic API market, 2018 - 2030 (USD Billion)
6.5.2.4 Innovative API
6.5.2.4.1 Innovative API market, 2018 - 2030 (USD Billion)
Chapter 7 Europe Active Pharmaceutical Ingredients Market: Segment Analysis, by Type of Manufacturer, 2018 - 2030 (USD Billion)
7.1 Definition and Scope
7.2 Type of Manufacturer Market Share Analysis, 2022 & 2030
7.3 Segment Dashboard
7.4 Europe API Market, by Type of Manufacturers, 2018 to 2030
7.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
7.5.1 Captive API
7.5.1.1 Captive API market, 2018 - 2030 (USD Billion)
7.5.2 Merchant API
7.5.2.1 Captive API market, 2018 - 2030 (USD Billion)
7.5.2.2 Merchant APIs market, By type (Revenue, USD Billion, 2018 - 2030)
7.5.2.3 Generic API
7.5.2.3.1 Generic APIs market, 2018 - 2030 (USD Billion)
7.5.2.4 Innovative API
7.5.2.4.1 Innovative APIs market, 2018 - 2030 (USD Billion)
7.5.2.5 Merchant API market, By type of synthesis (Revenue, USD Billion, 2018 - 2030)
7.5.2.6 Biotech
7.5.2.6.1 Biotech market, 2018 - 2030 (USD Billion)
7.5.2.7 Synthetic
7.5.2.7.1 Synthetic market, 2018 - 2030 (USD Billion)
Chapter 8 Europe Active Pharmaceutical Ingredients Market: Segment Analysis, by Type, 2018 - 2030 (USD Billion)
8.1 Definition and Scope
8.2 Type Market Share Analysis, 2022 & 2030
8.3 Segment Dashboard
8.4 Europe API Market, by Type, 2018 to 2030
8.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
8.5.1 Generic API
8.5.1.1 Generic API market, 2018 - 2030 (USD Billion)
8.5.2 Innovative API
8.5.2.1 Innovative API market, 2018 - 2030 (USD Billion)
Chapter 9 Europe Active Pharmaceutical Ingredients Market: Segment Analysis, by Application, 2018 - 2030 (USD Billion)
9.1 Definition and Scope
9.2 Application Market Share Analysis, 2022 & 2030
9.3 Segment Dashboard
9.4 Europe API Market, by Application, 2018 to 2030
9.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
9.5.1 Cardiovascular Diseases
9.5.1.1 Cardiovascular diseases market, 2018 - 2030 (USD Billion)
9.5.2 Oncology
9.5.2.1 Oncology market, 2018 - 2030 (USD Billion)
9.5.3 CNS and Neurology
9.5.3.1 CNS and neurology market, 2018 - 2030 (USD Billion)
9.5.4 Orthopedics
9.5.4.1 Orthopedics market, 2018 - 2030 (USD Billion)
9.5.5 Endocrinology
9.5.5.1 Endocrinology market, 2018 - 2030 (USD Billion)
9.5.6 Pulmonology
9.5.6.1 Pulmonology market, 2018 - 2030 (USD Billion)
9.5.7 Gastroenterology
9.5.7.1 Gastroenterology market, 2018 - 2030 (USD Billion)
9.5.8 Nephrology
9.5.8.1 Nephrology market, 2018 - 2030 (USD Billion)
9.5.9 Ophthalmology
9.5.9.1 Ophthalmology market, 2018 - 2030 (USD Billion)
9.5.10 Others
9.5.10.1 Others market, 2018 - 2030 (USD Billion)
Chapter 10 Europe Active Pharmaceutical Ingredients Market: Segment Analysis, by Type of Drug, 2018 - 2030 (USD Billion)
10.1 Definition and Scope
10.2 Type of Drug Market Share Analysis, 2022 & 2030
10.3 Segment Dashboard
10.4 Europe API Market, by Type of Drug, 2018 to 2030
10.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
10.5.1 Prescription
10.5.1.1 Prescription market, 2018 - 2030 (USD Billion)
10.5.2 OTC
10.5.2.1 OTC market, 2018 - 2030 (USD Billion)
Chapter 11 Europe Active Pharmaceutical Ingredients Market: Country Market Analysis, 2018 - 2030 (USD Billion)
11.1 Definition & Scope
11.2 Country Market Share Analysis, 2022 & 2030
11.3 Country Market Dashboard
11.4 Country Market Snapshot
11.5 SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
11.6 Europe
11.6.1 Europe API market, 2018 - 2030 (USD Billion)
11.6.2 UK
11.6.2.1 U.K. API market, 2018 - 2030 (USD Billion)
11.6.3 Germany
11.6.3.1 Germany API market, 2018 - 2030 (USD Billion)
11.6.4 Spain
11.6.4.1 Spain API market, 2018 - 2030 (USD Billion)
11.6.5 France
11.6.5.1 France API market, 2018 - 2030 (USD Billion)
11.6.6 Italy
11.6.6.1 Italy API market, 2018 - 2030 (USD Billion)
11.6.7 Russia
11.6.7.1 Russia API market, 2018 - 2030 (USD Billion)
11.6.8 Hungary
11.6.8.1 Hungary API market, 2018 - 2030 (USD Billion)
11.6.9 Poland
11.6.9.1 Poland API market, 2018 - 2030 (USD Billion)
11.6.10 Switzerland
11.6.10.1 Switzerland API market, 2018 - 2030 (USD Billion)
11.6.11 Sweden
11.6.11.1 Sweden API market, 2018 - 2030 (USD Billion)
Chapter 12 Europe Active Pharmaceutical Ingredients: Company Profiles
12.1 Merck & Co., Inc.
12.1.1 Company overview
12.1.2 Financial performance
12.1.3 Product benchmarking
12.1.4 Strategic initiatives
12.2 Boehringer Ingelheim International GmbH
12.2.1 Company overview
12.2.2 Financial performance
12.2.3 Product benchmarking
12.2.4 Strategic initiatives
12.3 Bristol-Myers Squibb Company
12.3.1 Company overview
12.3.2 Financial performance
12.3.3 Product benchmarking
12.3.4 Strategic initiatives
12.4 Cipla, Inc.
12.4.1 Company overview
12.4.2 Financial performance
12.4.3 Product benchmarking
12.4.4 Strategic initiatives
12.5 AbbVie, Inc.
12.5.1 Company overview
12.5.2 Financial performance
12.5.3 Product benchmarking
12.5.4 Strategic initiatives
12.6 Albemarle Corporation
12.6.1 Company overview
12.6.2 Financial performance
12.6.3 Product benchmarking
12.7 Aurobindo Pharma
12.7.1 Company overview
12.7.2 Financial performance
12.7.3 Product benchmarking
12.7.4 Strategic initiatives
12.8 Viatris Inc. (Mylan N.V.)
12.8.1 Company overview
12.8.2 Financial performance
12.8.3 Product benchmarking
12.8.4 Strategic initiatives
12.9 Teva Pharmaceutical Industries Ltd.
12.9.1 Company overview
12.9.2 Financial performance
12.9.3 Product benchmarking
12.9.4 Strategic initiatives
12.10 Sun Pharmaceutical Industries Ltd.
12.10.1 Company overview
12.10.2 Financial performance
12.10.3 Product benchmarking
12.10.4 Strategic initiatives
List of Tables
Table 1 List of Secondary Sources
TABLE 2 List of Abbreviations
TABLE 3 Regulatory Framework
TABLE 4 Europe Active Pharmaceutical Ingredients Market, By Region, 2018 - 2030 (USD Billion)
TABLE 5 Europe Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 6 Europe Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 7 Europe Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 8 Europe Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 22 Europe Active Pharmaceutical Ingredients Market, By Country, 2018 - 2030 (USD Billion)
TABLE 23 Europe Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 24 Europe Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 25 Europe Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 26 Europe Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 27 U.K. Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 28 U.K. Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 29 U.K. Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 30 U.K. Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 31 Germany Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 32 Germany Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 33 Germany America Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 34 Germany America Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 35 France Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 36 France Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 37 France Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 38 France Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 39 Spain Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 40 Spain Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 41 Spain Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 42 Spain Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 43 Italy Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 44 Italy Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 45 Italy Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 46 Italy Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 47 Russia Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 48 Russia Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 49 Russia Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 50 Russia Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 51 Switzerland Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 52 Switzerland Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 53 Switzerland Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 54 Switzerland Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 55 Poland Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 56 Poland Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 57 Poland Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 58 Poland Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 59 Hungary Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 60 Hungary Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 61 Hungary Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 62 Hungary Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 63 PortugalActive Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 64 Portugal Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 65 Portugal Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 66 Portugal Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 67 Sweden Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 68 Sweden Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 69 Sweden Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 70 Sweden Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
List of Figures
Fig. 1 Europe active pharmaceutical ingredients market segmentation
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value-chain-based sizing & forecasting
FIG. 7 QFD modeling for market share assessment
FIG. 8 Market formulation & validation
FIG. 9 Europe API market, segment outlook
FIG. 10 Europe API market, competitive outlook
FIG. 11 Europe API market outlook (2021)
FIG. 12 Penetration & growth prospect mapping
FIG. 13 User perspective analysis
FIG. 14 Market driver relevance analysis (Current & future impact)
FIG. 15 Global percentage of the population, by age group, 2050 and 2000
FIG. 16 Market restraint relevance analysis (Current & future impact)
FIG. 17 Porter’s five forces analysis
FIG. 18 PESTLE analysis
FIG. 19 Ansoff Matrix
FIG. 20 Heat map analysis
FIG. 21 Company market position analysis
FIG. 22 Company market position analysis
FIG. 23 Market differentiators
FIG. 24 Strategy mapping
FIG. 25 Europe API market: Type of Synthesis movement analysis
FIG. 26 Segment dashboard
FIG. 27 Europe API market type of synthesis outlook: Key takeaways
FIG. 28 Biotech API market, 2018 - 2030 (USD Billion)
FIG. 29 Biotech APIs Market, By Product (Revenue, USD Billion, 2018 - 2030)
FIG. 30 Monoclonal Antibodies market, 2018 - 2030 (USD Billion)
FIG. 31 Hormones market, 2018 - 2030 (USD Billion)
FIG. 32 Cytokines market, 2018 - 2030 (USD Billion)
FIG. 33 Recombinant Proteins market, 2018 - 2030 (USD Billion)
FIG. 34 Therapeutic Enzymes market, 2018 - 2030 (USD Billion)
FIG. 35 Vaccines market, 2018 - 2030 (USD Billion)
FIG. 36 Blood Factors market, 2018 - 2030 (USD Billion)
FIG. 37 Synthetic Europe API market, 2018 - 2030 (USD Billion)
FIG. 38 Europe API market: Type of manufacturers movement analysis
FIG. 39 Segment dashboard
FIG. 40 Europe API market Type of Manufacturers outlook: Key takeaways
FIG. 41 Captive Europe API market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 42 Merchant Europe API market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 43 Europe API market: Type movement analysis
FIG. 44 Segment dashboard
FIG. 45 Europe API market type outlook: Key takeaways
FIG. 46 Generic APIs market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 47 Innovative APIs market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 48 Europe API market: Type of Drug movement analysis
FIG. 49 Segment dashboard
FIG. 50 Europe API market type of drug outlook: Key takeaways
FIG. 51 Prescription market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 52 OTC market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 53 Europe API market: Application movement analysis
FIG. 54 Segment dashboard
FIG. 55 Europe API market application outlook: Key takeaways
FIG. 56 Cardiovascular diseases market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 57 Oncology market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 58 CNS & neurology market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 59 Orthopedics market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 60 Endocrinology market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 61 Pulmonology market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 62 Gastroenterology market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 63 Nephrology market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 64 Ophthalmology market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 65 Others market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 66 Regional outlook, 2021 & 2030
FIG. 67 Regional market dashboard
FIG. 68 Regional market place: Key takeaways
FIG. 69 Europe, SWOT Analysis
FIG. 70 Europe
FIG. 71 Europe market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 72 U.K.
FIG. 73 U.K. market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 74 Germany
FIG. 75 Germany market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 76 Spain
FIG. 77 Spain market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 78 France
FIG. 79 France market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 80 Italy
FIG. 81 Italy market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 82 Russia
FIG. 83 Russia market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 84 Hungary
FIG. 85 Hungary market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 86 Poland
FIG. 87 Poland market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 88 Switzerland
FIG. 89 Switzerland market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 90 Portugal
FIG. 91 Portugal market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 92 Denmark
FIG. 93 Denmark market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 94 Sweden
FIG. 95 Sweden market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 96 Strategy Mapping

Companies Mentioned

  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Company
  • Cipla, Inc.
  • AbbVie, Inc.
  • Albemarle Corporation
  • Aurobindo Pharma
  • Viatris Inc. (Mylan N.V.)
  • Teva Pharmaceutical Industries Ltd.
  • Sun Pharmaceutical Industries Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages130
PublishedMay 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 42.64 Billion
Forecasted Market Value ( USD ) by 2030 $ 66.7 Billion
Compound Annual Growth Rate5.7%
Regions CoveredEurope
No. of Companies Mentioned10

Related Topics

Related Reports

Active Pharmaceutical Ingredients Market Size, Share & Trends Analysis Report by Type Of Synthesis (Biotech, Synthetic), Type Of Manufacturer (Captive, Merchant), Type, Application, Type Of Drug, Region, and Segment Forecasts, 2024-2030 - Product Image

Active Pharmaceutical Ingredients Market Size, Share & Trends Analysis Report by Type Of Synthesis (Biotech, Synthetic), Type Of Manufacturer (Captive, Merchant), Type, Application, Type Of Drug, Region, and Segment Forecasts, 2024-2030

  • Report
  • 191 Pages
  • Global
From
Active Pharmaceutical Ingredient CDMO Market Size, Share & Trends Analysis Report By Product, By Synthesis, By Drug, By Application, By Workflow, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Active Pharmaceutical Ingredient CDMO Market Size, Share & Trends Analysis Report By Product, By Synthesis, By Drug, By Application, By Workflow, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 137 Pages
  • Global
From
Active Pharmaceutical Ingredients Market by Type, Synthesis, Manufacturer, Therapeutic Application - Global Forecast 2025-2030 - Product Image

Active Pharmaceutical Ingredients Market by Type, Synthesis, Manufacturer, Therapeutic Application - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Active Pharmaceutical Ingredients CDMO Market by Drug, Product, Synthesis, Workflow, Application - Global Forecast 2025-2030 - Product Image

Active Pharmaceutical Ingredients CDMO Market by Drug, Product, Synthesis, Workflow, Application - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Active Pharmaceutical Ingredient (API) - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Active Pharmaceutical Ingredient (API) - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From

About the Market

The Active Pharmaceutical Ingredient (API) market is a key component of the pharmaceutical manufacturing industry. APIs are the active ingredients in drugs that are responsible for their therapeutic effects. They are produced through chemical synthesis, biotechnological processes, or extraction from natural sources. APIs are then formulated into finished dosage forms such as tablets, capsules, and injectables. The API market is highly regulated, with stringent quality control measures in place to ensure the safety and efficacy of the drugs. The market is also highly competitive, with many companies vying for a share of the market. Companies in the API market are typically large, multinational corporations with extensive research and development capabilities. Some of the major players in the API market include Pfizer, Merck, Novartis, Sanofi, and GlaxoSmithKline. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.